The 26th Annual Meeting of the Japanese Society of Anti-Aging Medicine

Conflict of Interest (COI)

1. Applicability

  1. All authors and presenters, including members and non-members, who are presenting or speaking at a lecture or seminar at JAAM2026 meeting or study groups, trainings, and seminars organized by special interest or regional groups are required to disclose their COI in their abstract submission, detailing their financial relations with corporations involved in medical research or with for-profit organizations.
  2. It is up to the submitter to judge whether to disclose his/her COI. The Congress Secretariat of JAAM2026 is unable to answer questions related to COI judgment. However, please direct questions pertaining to the “Japanese Society of Anti-Aging Medicine COI Committee” to the JAAM Secretariat below.
Secretariat of the Japanese Society of Anti-Aging Medicine
Phone: +81-3-5651-7500   E-mail: coi@anti-aging.gr.jp

2. Personal Disclosure

It is the personal responsibility of the submitter to disclose if there is a conflict of interest related to the abstract to be presented. Abstracts that do not have any conflict of interest are not required to make a disclosure. It is mandatory to select whether the abstract has COI in the Abstract Submission Form. During the submission process, COI can only be indicated as either YES or NONE. COI is based on the following:

*Note:
Please disclose any conflicting interests with corporations, organizations or groups over the past one (1) year, counting backwards from the date of submission.
  1. Employment/leadership position/advisory role: JPY 1,000,000 or more annually from a commercial entity
  2. Stock ownership or options: Profit of JPY 1,000,000 or more annually from the stock of a company or ownership of 5% or more of the total shares of a company
  3. Patent royalties/licensing fees: JPY 1,000,000 or more per royalty/licensing fee annually
  4. Honoraria (e.g., lecture fees): JPY 1,000,000 or more annually from a commercial entity
  5. Manuscript fees: JPY 1,000,000 or more annually from a commercial entity
  6. Research funding: JPY 2,000,000 or more as annual payment to departments (department, field, or laboratory) that share research expenses from the same commercial entity
  7. Subsidies or donations: JPY 2,000,000 or more as annual payment to departments (department, field, or laboratory) that share subsidies or donations from the same commercial entity
  8. Endowed departments by commercial entities: If any of the authors belong to an endowed department sponsored by a commercial entity
  9. Travel fees, gifts, and others (except for research, training, education, and treatment): JPY 50,000 or more annually from a commercial entity

3. Onsite disclosures on slides and posters

COI disclosure on slides and posters should be indicated on the first slide (or after the introductory slide, with the title and author names), using the format 1-A for slide presentations or the prescribed format 1-B at the bottom for posters.